Lynparza，奥拉帕利片 Olaparib Tablets

This product is indicated for maintenance treatment of adult patients with advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who have germline or systemic BRCA mutations (gBRCAm or sBRCAm) and have achieved complete remission or partial remission with first-line platinum-containing chemotherapy. It is also indicated for maintenance treatment of adult patients with recurrent platinum-sensitive epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who have achieved complete remission or partial remission with platinum-containing chemotherapy.